MMJ BioScience Advancing Cannabis Multiple Sclerosis Study with QuintilesIMS as Certified Research Organization

MMJ International Holding’s, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and operation of medical cannabis healthcare businesses, today announced that its affiliate MMJ Bioscience as engaged QuintilesIMS has their Contract Research Organization.

Buffalo, New York (PRWEB) July 30, 2017

MMJ International Holding’s, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and operation of medical cannabis healthcare businesses, today announced that its affiliate MMJ Bioscience has engaged QuintilesIMS has their Contract Research Organization. QuintilesIMS has been recognized as the Best Full-service Provider Contract Research Organization (CRO).

 

With a global team of 50,000 QuintilesIMS will assist MMJ BioScience in providing a new level of understanding around what clinical outcomes lead to commercial success in the development process of MMJ Bioscience’s first pharmaceutical formulation of cannabinoid (CBD) derived from certain

... read more at: https://www.benzinga.com/pressreleases/17/07/p9845089/mmj-bioscience-advancing-cannabis-multiple-sclerosis-study-with-quintil

Leave a Reply

Your email address will not be published. Required fields are marked *